Tag

Ozempic

All articles tagged with #ozempic

health21 hours ago•16 min saved

GLP-1 Drugs Hint at Obesity Decline as Prescriptions Rise

New EPIC Research trackers using COSMOS data show GLP-1 prescriptions have risen fourfold since 2021, while obesity within the dataset declined from 42% to 41%, with GLP-1 users seeing a bigger drop (75% to 69%). While not nationally representative, the trend aligns with CDC estimates and other surveys that show rising GLP-1 use. Barriers like side effects, cost, and insurance limit adoption (about 12% of Americans), and cheaper generics abroad could arrive in five years. If adoption continues, obesity could decline further, though long-term effects remain uncertain.

via Gizmodo|

#epic-research #glp-1s #health

health9 days ago•48 min saved

Life After GLP-1s: Real Experiences With Stopping Weight-Loss Drugs

A BuzzFeed News piece compiles Reddit anecdotes about stopping GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) and notes a BMJ meta-analysis finding that people who stop weight loss meds regain weight about four times as fast as those leaving behavioral programs, typically returning to baseline in about 1.7 years. The responses span a spectrum: hunger and food cravings return; some report hair loss or energy dips; many regain weight, but others credit lasting lifestyle changes like mindful eating, calorie tracking, and regular exercise for maintaining weight or easing off gradually. The piece highlights ongoing questions about whether GLP-1s are a temporary boost or a long term tool, and invites more personal experiences.

via BuzzFeed|

#glp-1 #health #mounjaro

lifestyle13 days ago•8 min saved

Demi Moore's Cannes Look Ignites Health Concerns Over Her Slim Silhouette

Demi Moore’s appearances at the Cannes Film Festival sparked concern from fans who felt she looked unusually thin, with some speculating about weight‑loss drugs like Ozempic and recalling her past eating‑disorder battles, while others praised her style and defended her health.

via The Daily Beast|

#cannes-film-festival #demi-moore #eating-disorders

health16 days ago•9 min saved

GLP-1s Mask Cancer Clues, Delaying Diagnosis for Some Patients

The New York Post’s The Thin Line reports that GLP-1 medications like Ozempic and Mounjaro can blur gastrointestinal symptoms, leading some patients and even doctors to misattribute signs to drug side effects and delay colorectal cancer screening. Personal stories, including Brooke Hinderhan’s cancer diagnosis after years on GLP-1s and Michelle Lyson’s later-stage disease, illustrate how symptoms can overlap with treatment effects. Doctors caution that red-flag signs such as rectal bleeding or significant stool changes require evaluation, and emphasize that early detection greatly improves survival, underscoring that GLP-1s are not a guaranteed safeguard against cancer or its masking effects.

via New York Post|

#cancer-diagnosis #colorectal-cancer #glp-1

health16 days ago•6 min saved

Study finds GLP-1 weight loss carries greater social stigma than diet-only loss

New research finds people who slim down with GLP-1 drugs like Ozempic face greater social stigma than those who lose weight through diet/exercise or not at all, with stigma persisting after weight regain and potentially affecting care-seeking and health outcomes.

via New York Post|

#glp-1 #health #obesity

business18 days ago•3 min saved

Oral Ozempic and Wegovy Now Eligible for Amazon Same-Day Delivery

Novo Nordisk's oral versions of Ozempic and Wegovy are now available for Amazon same-day delivery, signaling a rapid access expansion after a strong launch that has drawn over a million patients in 16 weeks. The pills—taken daily rather than weekly injections—are expected to boost access to these GLP-1 therapies for diabetes and obesity, with the company citing broader cardiovascular, kidney, and liver benefits and hinting at possible future liver-disease treatments; pricing concessions with the Trump administration aim to broaden affordability, even as short-term effects weigh on the company’s financials.

via New York Post|

#amazon #business #glp-1

well-being19 days ago•21 min saved

New study flags smaller-than-expected muscle impact from GLP-1 medications

A new study suggests GLP-1 weight-loss drugs (such as Ozempic and Wegovy) may not cause as much muscle loss as previously feared, while reinforcing the importance of regular exercise to preserve muscle when taking these medications.

via The Washington Post|

#exercise #glp-1 #muscle-mass

health21 days ago•5 min saved

Ozempic Surge Reduces Bariatric Surgeries, Prompting Debate on Obesity Care

A Loyola University Chicago study using ACS-MBSAQIP data finds U.S. bariatric surgeries fell to about 177,297 in 2024 after peaking at 230,207 in 2022, suggesting GLP-1 drugs like Ozempic/Wegovy may be drawing patients away from surgical options, though surgery typically yields greater long‑term weight loss and lower costs. The shift also coincides with changing procedure mixes (sleeve gastrectomy ~58% in 2024, gastric bypass ~33%), and while GLP-1s are rising in use, economic and access factors (e.g., generics coming later in the U.S.) complicate the landscape. Experts stress that metabolic and bariatric surgery remains a highly effective option and that patients should be informed about all treatments.

via Gizmodo|

#bariatric-surgery #glp-1 #health

science25 days ago•22 min saved

Enzyme PapB could boost longevity and potency of Ozempic-like weight‑loss drugs

Scientists at the University of Utah found that the enzyme PapB can macrocyclize GLP-1–like drug peptides, increasing their stability and duration in the body, potentially making Ozempic/Wegovy‑type weight‑loss drugs more potent and longer‑lasting.

via New York Post|

#glp-1 #macrocyclization #ozempic

health25 days ago•3 min saved

Hydration Key to Ozempic Breath as Market Responds with Gum and Snacks

GLP-1 weight-loss drugs like Ozempic can cause dry mouth and bad breath, with hydration and saliva flow reducing bacterial growth linked to halitosis. Experts note dehydration and ketosis can contribute to breath changes, and suggest drinking water and sugar-free gum as practical fixes. The issue has even influenced consumer behavior, helping drive a rise in sales for gum and “functional snacks” (e.g., Hershey’s Ice Breakers and protein bars) as markets ride the trend.

via Gizmodo|

#bad-breath #glp-1 #health

health27 days ago•54 min saved

Eye-stroke signals surface with Wegovy, but the risk remains very low and unproven

A British Journal of Ophthalmology study analyzed FDA adverse-event reports and found ischemic optic neuropathy (ION) in fewer than 1% of Wegovy users (28 of 3,070 reports) versus 47 of 20,608 for Ozempic, suggesting a possible Wegovy-specific signal but not proving causation. The data come from voluntary reports and don’t establish true risk; experts say the overall risk is very low and Wegovy’s benefits for weight management likely outweigh this potential issue. Regulators advise urgent medical care if eyesight worsens quickly, and Rybelsus showed no notable link in the study; dose differences remain unproven as a factor.

via Live Science|

#eye-stroke #health #ischemic-optic-neuropathy

health-and-medicine1 month ago•6 min saved

Endoscopic gut reset shows promise to preserve weight loss after GLP-1 therapy

A blinded, sham-controlled trial presented at DDW 2026 suggests that duodenal mucosal resurfacing, a minimally invasive endoscopic procedure, may help people retain most of their GLP-1–driven weight loss after stopping Ozempic/semaglutide. In the early REMAIN-1 data (45 participants: 29 treated, 16 sham), those who received resurfacing regained significantly less weight than controls six months after discontinuing the drug, with some patients regaining as little as ~7 pounds and keeping over 80% of their weight loss; no serious complications were reported and recovery is quick. The regimen is investigational, with larger topline results from REMAIN-1 anticipated later in 2026.

via Science Daily|

#duodenal-mucosal-resurfacing #health-and-medicine #minimally-invasive-procedure

health1 month ago•32 min saved

Ozempic Side Effect Sparks Talk of an 'Ozempic Personality' and Motivation Shifts

Some Ozempic users report an “Ozempic Personality” marked by emotional flattening and reduced motivation for activities they once enjoyed (romance, exercise, music, socializing), a change researchers think may be linked to GLP-1 meds’ influence on dopamine. Dr. Drew frames this as a motivational shift rather than a true personality change and cautions that while there can be benefits, there are serious potential risks with Ozempic and similar drugs that require careful prescribing and monitoring.

via Yahoo|

#dopamine #glp-1 #health

health-and-wellness1 month ago•54 min saved

Glp-1 drugs and 'Ozempic personality': when weight loss comes with emotional blur

The Washington Post report highlights reports of emotional flattening and reduced motivation—often called 'Ozempic personality'—among some GLP-1 drug users (e.g., Ozempic/Wegovy). While many patients see weight loss and mood benefits, clinicians have documented anecdotes of dulled joy and motivation that sometimes improve when doses are lowered. The exact cause is unclear, with hypotheses ranging from pharmacological effects on dopamine-related reward pathways to psychological and lifestyle factors. Large studies show associations with mental-health changes and potential overall benefits in some cases, but causation isn’t established. Safety and personalized care remain the priority as researchers gather more data.

via The Boston Globe|

#anhedonia #dopamine #glp-1

health1 month ago•3 min saved

GLP-1 Weight-Loss Drugs Linked to Mood Improvement, Not Ozempic Stereotypes

Randomized trials of GLP-1 obesity medications show mood improvement in most patients with no increase in suicidality; experts, including Dr. Angela Fitch, emphasize that mood benefits do not imply a ‘Ozempic personality’ and that comprehensive care (counseling, behavioral management, exercise) is needed, while the market remains driven by metabolic benefits.

via Seeking Alpha|

#glp-1 #health #mood